nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—CYP3A4—prostate cancer	0.236	1	CbGaD
Isosorbide Mononitrate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0742	0.207	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Bicalutamide—prostate cancer	0.039	0.109	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Estramustine—prostate cancer	0.0362	0.101	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Abiraterone—prostate cancer	0.0323	0.09	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Flutamide—prostate cancer	0.0323	0.09	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Cabazitaxel—prostate cancer	0.0239	0.0666	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Estrone—prostate cancer	0.0233	0.0651	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0208	0.058	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Conjugated Estrogens—prostate cancer	0.0153	0.0426	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Mitoxantrone—prostate cancer	0.0139	0.0387	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Estradiol—prostate cancer	0.0134	0.0374	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Prednisone—prostate cancer	0.0115	0.0321	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Etoposide—prostate cancer	0.00876	0.0244	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Docetaxel—prostate cancer	0.00801	0.0223	CbGbCtD
Isosorbide Mononitrate—GUCY1A2—prostate gland—prostate cancer	0.00691	0.125	CbGeAlD
Isosorbide Mononitrate—CYP3A4—Doxorubicin—prostate cancer	0.00597	0.0166	CbGbCtD
Isosorbide Mononitrate—GUCY1A3—prostate gland—prostate cancer	0.00435	0.0788	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—prostate gland—prostate cancer	0.00432	0.0782	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—seminal vesicle—prostate cancer	0.00368	0.0666	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—seminal vesicle—prostate cancer	0.00365	0.0661	CbGeAlD
Isosorbide Mononitrate—CYP3A4—urine—prostate cancer	0.00346	0.0627	CbGeAlD
Isosorbide Mononitrate—GUCY1A2—testis—prostate cancer	0.00304	0.0551	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—renal system—prostate cancer	0.00296	0.0537	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—renal system—prostate cancer	0.00294	0.0533	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—urethra—prostate cancer	0.00291	0.0527	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—urethra—prostate cancer	0.00289	0.0524	CbGeAlD
Isosorbide Mononitrate—Isosorbide Dinitrate—CYP2E1—prostate cancer	0.00225	0.614	CrCbGaD
Isosorbide Mononitrate—GUCY1A3—bone marrow—prostate cancer	0.00224	0.0406	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—bone marrow—prostate cancer	0.00223	0.0403	CbGeAlD
Isosorbide Mononitrate—GUCY1A2—lymph node—prostate cancer	0.00221	0.0399	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—testis—prostate cancer	0.00192	0.0347	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—testis—prostate cancer	0.0019	0.0344	CbGeAlD
Isosorbide Mononitrate—Isosorbide Dinitrate—CYP3A4—prostate cancer	0.00142	0.386	CrCbGaD
Isosorbide Mononitrate—GUCY1A3—lymph node—prostate cancer	0.00139	0.0252	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—lymph node—prostate cancer	0.00138	0.025	CbGeAlD
Isosorbide Mononitrate—CYP3A4—renal system—prostate cancer	0.000847	0.0153	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—prostate cancer	9.88e-05	0.00142	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CREBBP—prostate cancer	9.64e-05	0.00139	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CREBBP—prostate cancer	9.64e-05	0.00139	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	9.54e-05	0.00137	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	9.54e-05	0.00137	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IGF1—prostate cancer	9.52e-05	0.00137	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IGF1—prostate cancer	9.52e-05	0.00137	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	9.43e-05	0.00136	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	9.41e-05	0.00135	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CG—prostate cancer	9.27e-05	0.00133	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—EGF—prostate cancer	9.16e-05	0.00132	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CD—prostate cancer	9.14e-05	0.00132	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CD—prostate cancer	9.14e-05	0.00132	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SERPINE1—prostate cancer	9.04e-05	0.0013	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SERPINE1—prostate cancer	9.04e-05	0.0013	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTM3—prostate cancer	8.97e-05	0.00129	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	8.97e-05	0.00129	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	8.85e-05	0.00127	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	8.85e-05	0.00127	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	8.72e-05	0.00126	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	8.65e-05	0.00125	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—NOS3—prostate cancer	8.63e-05	0.00124	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—NOS3—prostate cancer	8.63e-05	0.00124	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	8.59e-05	0.00124	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CREBBP—prostate cancer	8.59e-05	0.00124	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	8.5e-05	0.00122	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—NAT1—prostate cancer	8.5e-05	0.00122	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IGF1—prostate cancer	8.49e-05	0.00122	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	8.48e-05	0.00122	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	8.41e-05	0.00121	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—JAK2—prostate cancer	8.39e-05	0.00121	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—JAK2—prostate cancer	8.39e-05	0.00121	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	8.39e-05	0.00121	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	8.29e-05	0.00119	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	8.27e-05	0.00119	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	8.18e-05	0.00118	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CD—prostate cancer	8.15e-05	0.00117	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SERPINE1—prostate cancer	8.06e-05	0.00116	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CB—prostate cancer	7.97e-05	0.00115	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CB—prostate cancer	7.97e-05	0.00115	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	7.94e-05	0.00114	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	7.84e-05	0.00113	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	7.77e-05	0.00112	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—NOS3—prostate cancer	7.7e-05	0.00111	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	7.57e-05	0.00109	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—JAK2—prostate cancer	7.48e-05	0.00108	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IL2—prostate cancer	7.32e-05	0.00105	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IL2—prostate cancer	7.32e-05	0.00105	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	7.3e-05	0.00105	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	7.13e-05	0.00103	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CB—prostate cancer	7.1e-05	0.00102	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	7.05e-05	0.00102	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	6.97e-05	0.001	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	6.96e-05	0.001	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	6.72e-05	0.000968	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	6.68e-05	0.000962	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	6.61e-05	0.000952	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	6.6e-05	0.00095	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—EP300—prostate cancer	6.57e-05	0.000946	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—EP300—prostate cancer	6.57e-05	0.000946	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IL2—prostate cancer	6.52e-05	0.000939	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	6.52e-05	0.000939	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	6.44e-05	0.000928	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	6.44e-05	0.000927	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SRC—prostate cancer	6.39e-05	0.00092	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SRC—prostate cancer	6.39e-05	0.00092	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	6.38e-05	0.000918	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	6.36e-05	0.000915	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	6.28e-05	0.000905	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	6.27e-05	0.000902	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—VEGFA—prostate cancer	6.22e-05	0.000896	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—VEGFA—prostate cancer	6.22e-05	0.000896	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	6.2e-05	0.000893	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	6.13e-05	0.000883	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	6.06e-05	0.000873	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—EP300—prostate cancer	5.85e-05	0.000843	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	5.72e-05	0.000823	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TGFB1—prostate cancer	5.71e-05	0.000822	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TGFB1—prostate cancer	5.71e-05	0.000822	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SRC—prostate cancer	5.69e-05	0.00082	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	5.67e-05	0.000817	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	5.6e-05	0.000806	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—VEGFA—prostate cancer	5.54e-05	0.000798	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA3—prostate cancer	5.48e-05	0.000789	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	5.42e-05	0.00078	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	5.4e-05	0.000778	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—KRAS—prostate cancer	5.29e-05	0.000761	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—KRAS—prostate cancer	5.29e-05	0.000761	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	5.17e-05	0.000744	CbGpPWpGaD
Isosorbide Mononitrate—Urethral disorder—Epirubicin—prostate cancer	5.12e-05	0.000185	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Prednisone—prostate cancer	5.11e-05	0.000184	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	5.09e-05	0.000734	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TGFB1—prostate cancer	5.09e-05	0.000733	CbGpPWpGaD
Isosorbide Mononitrate—Epistaxis—Doxorubicin—prostate cancer	5.08e-05	0.000183	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Capecitabine—prostate cancer	5.08e-05	0.000183	CcSEcCtD
Isosorbide Mononitrate—Nausea—Estradiol—prostate cancer	5.07e-05	0.000183	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	5.07e-05	0.000729	CbGpPWpGaD
Isosorbide Mononitrate—Vomiting—Mitoxantrone—prostate cancer	5.06e-05	0.000182	CcSEcCtD
Isosorbide Mononitrate—Sinusitis—Doxorubicin—prostate cancer	5.05e-05	0.000182	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Epirubicin—prostate cancer	5.03e-05	0.000181	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Prednisone—prostate cancer	5.02e-05	0.000181	CcSEcCtD
Isosorbide Mononitrate—Rash—Mitoxantrone—prostate cancer	5.02e-05	0.000181	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Mitoxantrone—prostate cancer	5.01e-05	0.000181	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.01e-05	0.000181	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	5.01e-05	0.000722	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA4—prostate cancer	5.01e-05	0.000722	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	5e-05	0.00072	CbGpPWpGaD
Isosorbide Mononitrate—Headache—Mitoxantrone—prostate cancer	4.99e-05	0.00018	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Capecitabine—prostate cancer	4.98e-05	0.000179	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Docetaxel—prostate cancer	4.98e-05	0.000179	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Prednisone—prostate cancer	4.95e-05	0.000178	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Prednisone—prostate cancer	4.95e-05	0.000178	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	4.94e-05	0.000712	CbGpPWpGaD
Isosorbide Mononitrate—Paraesthesia—Docetaxel—prostate cancer	4.94e-05	0.000178	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Prednisone—prostate cancer	4.93e-05	0.000178	CcSEcCtD
Isosorbide Mononitrate—Bradycardia—Doxorubicin—prostate cancer	4.92e-05	0.000177	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	4.92e-05	0.000708	CbGpPWpGaD
Isosorbide Mononitrate—Dyspnoea—Docetaxel—prostate cancer	4.9e-05	0.000177	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Docetaxel—prostate cancer	4.89e-05	0.000176	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Prednisone—prostate cancer	4.89e-05	0.000176	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA2—prostate cancer	4.88e-05	0.000703	CbGpPWpGaD
Isosorbide Mononitrate—Hypersensitivity—Etoposide—prostate cancer	4.88e-05	0.000176	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Epirubicin—prostate cancer	4.87e-05	0.000176	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CA—prostate cancer	4.86e-05	0.0007	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CA—prostate cancer	4.86e-05	0.0007	CbGpPWpGaD
Isosorbide Mononitrate—Haemoglobin—Doxorubicin—prostate cancer	4.86e-05	0.000175	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.85e-05	0.000175	CcSEcCtD
Isosorbide Mononitrate—Flushing—Epirubicin—prostate cancer	4.85e-05	0.000175	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Epirubicin—prostate cancer	4.85e-05	0.000175	CcSEcCtD
Isosorbide Mononitrate—Rhinitis—Doxorubicin—prostate cancer	4.84e-05	0.000175	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Docetaxel—prostate cancer	4.84e-05	0.000175	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Doxorubicin—prostate cancer	4.83e-05	0.000174	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	4.82e-05	0.000695	CbGpPWpGaD
Isosorbide Mononitrate—Insomnia—Capecitabine—prostate cancer	4.82e-05	0.000174	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Doxorubicin—prostate cancer	4.81e-05	0.000173	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Doxorubicin—prostate cancer	4.8e-05	0.000173	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Capecitabine—prostate cancer	4.78e-05	0.000172	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Docetaxel—prostate cancer	4.78e-05	0.000172	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Doxorubicin—prostate cancer	4.77e-05	0.000172	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Doxorubicin—prostate cancer	4.76e-05	0.000172	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	4.76e-05	0.000685	CbGpPWpGaD
Isosorbide Mononitrate—Gastrointestinal disorder—Docetaxel—prostate cancer	4.75e-05	0.000171	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Etoposide—prostate cancer	4.75e-05	0.000171	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Capecitabine—prostate cancer	4.75e-05	0.000171	CcSEcCtD
Isosorbide Mononitrate—Oedema—Prednisone—prostate cancer	4.74e-05	0.000171	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Docetaxel—prostate cancer	4.74e-05	0.000171	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Doxorubicin—prostate cancer	4.74e-05	0.000171	CcSEcCtD
Isosorbide Mononitrate—Nausea—Mitoxantrone—prostate cancer	4.73e-05	0.00017	CcSEcCtD
Isosorbide Mononitrate—Infection—Prednisone—prostate cancer	4.71e-05	0.00017	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—KRAS—prostate cancer	4.71e-05	0.000679	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA1—prostate cancer	4.71e-05	0.000678	CbGpPWpGaD
Isosorbide Mononitrate—Constipation—Docetaxel—prostate cancer	4.7e-05	0.00017	CcSEcCtD
Isosorbide Mononitrate—Pain—Docetaxel—prostate cancer	4.7e-05	0.00017	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TP53—prostate cancer	4.7e-05	0.000677	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TP53—prostate cancer	4.7e-05	0.000677	CbGpPWpGaD
Isosorbide Mononitrate—Dyspepsia—Capecitabine—prostate cancer	4.69e-05	0.000169	CcSEcCtD
Isosorbide Mononitrate—Chills—Epirubicin—prostate cancer	4.69e-05	0.000169	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Etoposide—prostate cancer	4.68e-05	0.000169	CcSEcCtD
Isosorbide Mononitrate—Shock—Prednisone—prostate cancer	4.67e-05	0.000168	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Epirubicin—prostate cancer	4.67e-05	0.000168	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—NAT2—prostate cancer	4.66e-05	0.000671	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTO1—prostate cancer	4.66e-05	0.000671	CbGpPWpGaD
Isosorbide Mononitrate—Visual impairment—Doxorubicin—prostate cancer	4.66e-05	0.000168	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Prednisone—prostate cancer	4.65e-05	0.000168	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Prednisone—prostate cancer	4.63e-05	0.000167	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Capecitabine—prostate cancer	4.63e-05	0.000167	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Prednisone—prostate cancer	4.61e-05	0.000166	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Capecitabine—prostate cancer	4.6e-05	0.000166	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	4.59e-05	0.000662	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	4.59e-05	0.000662	CbGpPWpGaD
Isosorbide Mononitrate—Fatigue—Capecitabine—prostate cancer	4.59e-05	0.000166	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Prednisone—prostate cancer	4.59e-05	0.000165	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Epirubicin—prostate cancer	4.58e-05	0.000165	CcSEcCtD
Isosorbide Mononitrate—Pain—Capecitabine—prostate cancer	4.55e-05	0.000164	CcSEcCtD
Isosorbide Mononitrate—Constipation—Capecitabine—prostate cancer	4.55e-05	0.000164	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Epirubicin—prostate cancer	4.55e-05	0.000164	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Docetaxel—prostate cancer	4.53e-05	0.000163	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Etoposide—prostate cancer	4.53e-05	0.000163	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Prednisone—prostate cancer	4.52e-05	0.000163	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Doxorubicin—prostate cancer	4.51e-05	0.000162	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Docetaxel—prostate cancer	4.5e-05	0.000162	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Doxorubicin—prostate cancer	4.48e-05	0.000162	CcSEcCtD
Isosorbide Mononitrate—Flushing—Doxorubicin—prostate cancer	4.48e-05	0.000162	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Epirubicin—prostate cancer	4.48e-05	0.000162	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	4.47e-05	0.000643	CbGpPWpGaD
Isosorbide Mononitrate—Tension—Epirubicin—prostate cancer	4.46e-05	0.000161	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Epirubicin—prostate cancer	4.45e-05	0.000161	CcSEcCtD
Isosorbide Mononitrate—Nervousness—Epirubicin—prostate cancer	4.42e-05	0.000159	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	4.41e-05	0.000634	CbGpPWpGaD
Isosorbide Mononitrate—Back pain—Epirubicin—prostate cancer	4.4e-05	0.000159	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Capecitabine—prostate cancer	4.39e-05	0.000158	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Etoposide—prostate cancer	4.38e-05	0.000158	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Epirubicin—prostate cancer	4.37e-05	0.000158	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Capecitabine—prostate cancer	4.36e-05	0.000157	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Docetaxel—prostate cancer	4.35e-05	0.000157	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Docetaxel—prostate cancer	4.35e-05	0.000157	CcSEcCtD
Isosorbide Mononitrate—Chills—Doxorubicin—prostate cancer	4.34e-05	0.000156	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CA—prostate cancer	4.33e-05	0.000624	CbGpPWpGaD
Isosorbide Mononitrate—Musculoskeletal discomfort—Prednisone—prostate cancer	4.32e-05	0.000156	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Doxorubicin—prostate cancer	4.32e-05	0.000156	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Prednisone—prostate cancer	4.29e-05	0.000155	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Epirubicin—prostate cancer	4.28e-05	0.000155	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Prednisone—prostate cancer	4.26e-05	0.000154	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Doxorubicin—prostate cancer	4.23e-05	0.000153	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Epirubicin—prostate cancer	4.22e-05	0.000152	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Capecitabine—prostate cancer	4.21e-05	0.000152	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Capecitabine—prostate cancer	4.21e-05	0.000152	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Etoposide—prostate cancer	4.21e-05	0.000152	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Doxorubicin—prostate cancer	4.21e-05	0.000152	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Epirubicin—prostate cancer	4.2e-05	0.000152	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TP53—prostate cancer	4.19e-05	0.000603	CbGpPWpGaD
Isosorbide Mononitrate—Agitation—Epirubicin—prostate cancer	4.18e-05	0.000151	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Prednisone—prostate cancer	4.18e-05	0.000151	CcSEcCtD
Isosorbide Mononitrate—Rash—Etoposide—prostate cancer	4.17e-05	0.000151	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Etoposide—prostate cancer	4.17e-05	0.00015	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	4.15e-05	0.000598	CbGpPWpGaD
Isosorbide Mononitrate—Headache—Etoposide—prostate cancer	4.15e-05	0.00015	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Doxorubicin—prostate cancer	4.15e-05	0.000149	CcSEcCtD
Isosorbide Mononitrate—Tension—Doxorubicin—prostate cancer	4.13e-05	0.000149	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Prednisone—prostate cancer	4.12e-05	0.000149	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Doxorubicin—prostate cancer	4.12e-05	0.000149	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	4.11e-05	0.000591	CbGpPWpGaD
Isosorbide Mononitrate—Malaise—Epirubicin—prostate cancer	4.1e-05	0.000148	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	4.1e-05	0.00059	CbGpPWpGaD
Isosorbide Mononitrate—Fatigue—Prednisone—prostate cancer	4.09e-05	0.000148	CcSEcCtD
Isosorbide Mononitrate—Nervousness—Doxorubicin—prostate cancer	4.09e-05	0.000147	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Epirubicin—prostate cancer	4.08e-05	0.000147	CcSEcCtD
Isosorbide Mononitrate—Syncope—Epirubicin—prostate cancer	4.08e-05	0.000147	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Epirubicin—prostate cancer	4.07e-05	0.000147	CcSEcCtD
Isosorbide Mononitrate—Back pain—Doxorubicin—prostate cancer	4.07e-05	0.000147	CcSEcCtD
Isosorbide Mononitrate—Constipation—Prednisone—prostate cancer	4.06e-05	0.000146	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Docetaxel—prostate cancer	4.05e-05	0.000146	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Doxorubicin—prostate cancer	4.04e-05	0.000146	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Epirubicin—prostate cancer	4.02e-05	0.000145	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Epirubicin—prostate cancer	4e-05	0.000144	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—AKT1—prostate cancer	3.97e-05	0.000571	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—AKT1—prostate cancer	3.97e-05	0.000571	CbGpPWpGaD
Isosorbide Mononitrate—Cough—Epirubicin—prostate cancer	3.97e-05	0.000143	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Doxorubicin—prostate cancer	3.96e-05	0.000143	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Docetaxel—prostate cancer	3.95e-05	0.000142	CcSEcCtD
Isosorbide Mononitrate—Nausea—Etoposide—prostate cancer	3.93e-05	0.000142	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Epirubicin—prostate cancer	3.93e-05	0.000142	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Capecitabine—prostate cancer	3.92e-05	0.000142	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Prednisone—prostate cancer	3.91e-05	0.000141	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	3.91e-05	0.000563	CbGpPWpGaD
Isosorbide Mononitrate—Ill-defined disorder—Doxorubicin—prostate cancer	3.9e-05	0.000141	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Docetaxel—prostate cancer	3.89e-05	0.00014	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Doxorubicin—prostate cancer	3.89e-05	0.00014	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Prednisone—prostate cancer	3.88e-05	0.00014	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Epirubicin—prostate cancer	3.87e-05	0.00014	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Epirubicin—prostate cancer	3.87e-05	0.00014	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Epirubicin—prostate cancer	3.87e-05	0.00014	CcSEcCtD
Isosorbide Mononitrate—Agitation—Doxorubicin—prostate cancer	3.87e-05	0.000139	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	3.86e-05	0.000557	CbGpPWpGaD
Isosorbide Mononitrate—Anxiety—Epirubicin—prostate cancer	3.86e-05	0.000139	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Epirubicin—prostate cancer	3.82e-05	0.000138	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Capecitabine—prostate cancer	3.82e-05	0.000138	CcSEcCtD
Isosorbide Mononitrate—Malaise—Doxorubicin—prostate cancer	3.79e-05	0.000137	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Epirubicin—prostate cancer	3.79e-05	0.000137	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Doxorubicin—prostate cancer	3.78e-05	0.000136	CcSEcCtD
Isosorbide Mononitrate—Syncope—Doxorubicin—prostate cancer	3.77e-05	0.000136	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Capecitabine—prostate cancer	3.77e-05	0.000136	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Doxorubicin—prostate cancer	3.77e-05	0.000136	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Docetaxel—prostate cancer	3.76e-05	0.000136	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Prednisone—prostate cancer	3.75e-05	0.000135	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Prednisone—prostate cancer	3.75e-05	0.000135	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Epirubicin—prostate cancer	3.74e-05	0.000135	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—HPGDS—prostate cancer	3.72e-05	0.000536	CbGpPWpGaD
Isosorbide Mononitrate—Palpitations—Doxorubicin—prostate cancer	3.72e-05	0.000134	CcSEcCtD
Isosorbide Mononitrate—Oedema—Epirubicin—prostate cancer	3.71e-05	0.000134	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	3.7e-05	0.000533	CbGpPWpGaD
Isosorbide Mononitrate—Loss of consciousness—Doxorubicin—prostate cancer	3.7e-05	0.000133	CcSEcCtD
Isosorbide Mononitrate—Infection—Epirubicin—prostate cancer	3.69e-05	0.000133	CcSEcCtD
Isosorbide Mononitrate—Cough—Doxorubicin—prostate cancer	3.67e-05	0.000132	CcSEcCtD
Isosorbide Mononitrate—Shock—Epirubicin—prostate cancer	3.65e-05	0.000132	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	3.65e-05	0.000526	CbGpPWpGaD
Isosorbide Mononitrate—Diarrhoea—Capecitabine—prostate cancer	3.64e-05	0.000131	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Epirubicin—prostate cancer	3.64e-05	0.000131	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Docetaxel—prostate cancer	3.64e-05	0.000131	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Epirubicin—prostate cancer	3.63e-05	0.000131	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Doxorubicin—prostate cancer	3.63e-05	0.000131	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Epirubicin—prostate cancer	3.62e-05	0.000131	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTT1—prostate cancer	3.61e-05	0.00052	CbGpPWpGaD
Isosorbide Mononitrate—Skin disorder—Epirubicin—prostate cancer	3.6e-05	0.00013	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Epirubicin—prostate cancer	3.59e-05	0.000129	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Doxorubicin—prostate cancer	3.58e-05	0.000129	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Doxorubicin—prostate cancer	3.58e-05	0.000129	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Doxorubicin—prostate cancer	3.58e-05	0.000129	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	3.57e-05	0.000514	CbGpPWpGaD
Isosorbide Mononitrate—Anxiety—Doxorubicin—prostate cancer	3.57e-05	0.000129	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Doxorubicin—prostate cancer	3.54e-05	0.000128	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—AKT1—prostate cancer	3.54e-05	0.000509	CbGpPWpGaD
Isosorbide Mononitrate—Anorexia—Epirubicin—prostate cancer	3.54e-05	0.000128	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Capecitabine—prostate cancer	3.52e-05	0.000127	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Doxorubicin—prostate cancer	3.5e-05	0.000126	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Docetaxel—prostate cancer	3.5e-05	0.000126	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Prednisone—prostate cancer	3.5e-05	0.000126	CcSEcCtD
Isosorbide Mononitrate—Rash—Docetaxel—prostate cancer	3.47e-05	0.000125	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Epirubicin—prostate cancer	3.47e-05	0.000125	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Docetaxel—prostate cancer	3.47e-05	0.000125	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Doxorubicin—prostate cancer	3.46e-05	0.000125	CcSEcCtD
Isosorbide Mononitrate—Headache—Docetaxel—prostate cancer	3.45e-05	0.000124	CcSEcCtD
Isosorbide Mononitrate—Oedema—Doxorubicin—prostate cancer	3.43e-05	0.000124	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	3.43e-05	0.000493	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	3.42e-05	0.000492	CbGpPWpGaD
Isosorbide Mononitrate—Infection—Doxorubicin—prostate cancer	3.41e-05	0.000123	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Prednisone—prostate cancer	3.4e-05	0.000123	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Capecitabine—prostate cancer	3.39e-05	0.000122	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.38e-05	0.000122	CcSEcCtD
Isosorbide Mononitrate—Shock—Doxorubicin—prostate cancer	3.38e-05	0.000122	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	3.37e-05	0.000486	CbGpPWpGaD
Isosorbide Mononitrate—Nervous system disorder—Doxorubicin—prostate cancer	3.37e-05	0.000121	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Doxorubicin—prostate cancer	3.36e-05	0.000121	CcSEcCtD
Isosorbide Mononitrate—Rash—Capecitabine—prostate cancer	3.36e-05	0.000121	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Prednisone—prostate cancer	3.36e-05	0.000121	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Epirubicin—prostate cancer	3.36e-05	0.000121	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Capecitabine—prostate cancer	3.36e-05	0.000121	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Doxorubicin—prostate cancer	3.35e-05	0.000121	CcSEcCtD
Isosorbide Mononitrate—Headache—Capecitabine—prostate cancer	3.34e-05	0.00012	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Doxorubicin—prostate cancer	3.33e-05	0.00012	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Epirubicin—prostate cancer	3.33e-05	0.00012	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Doxorubicin—prostate cancer	3.32e-05	0.00012	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Epirubicin—prostate cancer	3.31e-05	0.000119	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Epirubicin—prostate cancer	3.3e-05	0.000119	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Doxorubicin—prostate cancer	3.27e-05	0.000118	CcSEcCtD
Isosorbide Mononitrate—Nausea—Docetaxel—prostate cancer	3.27e-05	0.000118	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Epirubicin—prostate cancer	3.27e-05	0.000118	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—NCOA2—prostate cancer	3.26e-05	0.000469	CbGpPWpGaD
Isosorbide Mononitrate—Diarrhoea—Prednisone—prostate cancer	3.25e-05	0.000117	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Epirubicin—prostate cancer	3.23e-05	0.000116	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Doxorubicin—prostate cancer	3.21e-05	0.000116	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Epirubicin—prostate cancer	3.2e-05	0.000116	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Epirubicin—prostate cancer	3.2e-05	0.000115	CcSEcCtD
Isosorbide Mononitrate—Pain—Epirubicin—prostate cancer	3.17e-05	0.000114	CcSEcCtD
Isosorbide Mononitrate—Constipation—Epirubicin—prostate cancer	3.17e-05	0.000114	CcSEcCtD
Isosorbide Mononitrate—Nausea—Capecitabine—prostate cancer	3.16e-05	0.000114	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Prednisone—prostate cancer	3.14e-05	0.000113	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.13e-05	0.000113	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Doxorubicin—prostate cancer	3.11e-05	0.000112	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Doxorubicin—prostate cancer	3.08e-05	0.000111	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Doxorubicin—prostate cancer	3.06e-05	0.00011	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Epirubicin—prostate cancer	3.06e-05	0.00011	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Doxorubicin—prostate cancer	3.05e-05	0.00011	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	3.04e-05	0.000437	CbGpPWpGaD
Isosorbide Mononitrate—Gastrointestinal pain—Epirubicin—prostate cancer	3.03e-05	0.000109	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Doxorubicin—prostate cancer	3.02e-05	0.000109	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Prednisone—prostate cancer	3.02e-05	0.000109	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	2.99e-05	0.000431	CbGpPWpGaD
Isosorbide Mononitrate—Rash—Prednisone—prostate cancer	2.99e-05	0.000108	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Prednisone—prostate cancer	2.99e-05	0.000108	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Doxorubicin—prostate cancer	2.98e-05	0.000108	CcSEcCtD
Isosorbide Mononitrate—Headache—Prednisone—prostate cancer	2.97e-05	0.000107	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.96e-05	0.000107	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Doxorubicin—prostate cancer	2.96e-05	0.000107	CcSEcCtD
Isosorbide Mononitrate—Pain—Doxorubicin—prostate cancer	2.94e-05	0.000106	CcSEcCtD
Isosorbide Mononitrate—Constipation—Doxorubicin—prostate cancer	2.94e-05	0.000106	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Epirubicin—prostate cancer	2.93e-05	0.000106	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Epirubicin—prostate cancer	2.93e-05	0.000106	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	2.88e-05	0.000414	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	2.84e-05	0.000409	CbGpPWpGaD
Isosorbide Mononitrate—Feeling abnormal—Doxorubicin—prostate cancer	2.83e-05	0.000102	CcSEcCtD
Isosorbide Mononitrate—Nausea—Prednisone—prostate cancer	2.82e-05	0.000102	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Doxorubicin—prostate cancer	2.81e-05	0.000101	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GGT1—prostate cancer	2.79e-05	0.000401	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.75e-05	0.000395	CbGpPWpGaD
Isosorbide Mononitrate—Hypersensitivity—Epirubicin—prostate cancer	2.73e-05	9.86e-05	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Doxorubicin—prostate cancer	2.71e-05	9.79e-05	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Doxorubicin—prostate cancer	2.71e-05	9.79e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.71e-05	0.00039	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.67e-05	0.000384	CbGpPWpGaD
Isosorbide Mononitrate—Asthenia—Epirubicin—prostate cancer	2.66e-05	9.6e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Epirubicin—prostate cancer	2.63e-05	9.47e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.61e-05	0.000376	CbGpPWpGaD
Isosorbide Mononitrate—Diarrhoea—Epirubicin—prostate cancer	2.54e-05	9.16e-05	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Doxorubicin—prostate cancer	2.53e-05	9.12e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—COMT—prostate cancer	2.52e-05	0.000362	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.5e-05	0.000361	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.48e-05	0.000357	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.47e-05	0.000356	CbGpPWpGaD
Isosorbide Mononitrate—Asthenia—Doxorubicin—prostate cancer	2.46e-05	8.88e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Epirubicin—prostate cancer	2.45e-05	8.85e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Doxorubicin—prostate cancer	2.43e-05	8.76e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Epirubicin—prostate cancer	2.36e-05	8.51e-05	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Doxorubicin—prostate cancer	2.35e-05	8.47e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Epirubicin—prostate cancer	2.34e-05	8.44e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Epirubicin—prostate cancer	2.34e-05	8.43e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Epirubicin—prostate cancer	2.32e-05	8.38e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.3e-05	0.000331	CbGpPWpGaD
Isosorbide Mononitrate—Dizziness—Doxorubicin—prostate cancer	2.27e-05	8.19e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.27e-05	0.000327	CbGpPWpGaD
Isosorbide Mononitrate—Nausea—Epirubicin—prostate cancer	2.2e-05	7.95e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Doxorubicin—prostate cancer	2.18e-05	7.87e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.18e-05	0.000314	CbGpPWpGaD
Isosorbide Mononitrate—Rash—Doxorubicin—prostate cancer	2.16e-05	7.81e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Doxorubicin—prostate cancer	2.16e-05	7.8e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—HAO1—prostate cancer	2.15e-05	0.00031	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.15e-05	0.00031	CbGpPWpGaD
Isosorbide Mononitrate—Headache—Doxorubicin—prostate cancer	2.15e-05	7.76e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Doxorubicin—prostate cancer	2.04e-05	7.35e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—GRHL1—prostate cancer	1.75e-05	0.000253	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ADI1—prostate cancer	1.75e-05	0.000253	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TST—prostate cancer	1.75e-05	0.000253	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CSAD—prostate cancer	1.75e-05	0.000253	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CBR1—prostate cancer	1.75e-05	0.000253	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PSAT1—prostate cancer	1.75e-05	0.000253	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.63e-05	0.000235	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.63e-05	0.000235	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GRHPR—prostate cancer	1.63e-05	0.000235	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CKMT2—prostate cancer	1.63e-05	0.000235	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AOX1—prostate cancer	1.53e-05	0.000221	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PGAM2—prostate cancer	1.53e-05	0.000221	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.53e-05	0.000221	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NAGLU—prostate cancer	1.53e-05	0.000221	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.53e-05	0.000221	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—RFK—prostate cancer	1.53e-05	0.000221	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTM3—prostate cancer	1.53e-05	0.000221	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.45e-05	0.000209	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AMACR—prostate cancer	1.45e-05	0.000209	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—DEGS1—prostate cancer	1.45e-05	0.000209	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NAT1—prostate cancer	1.45e-05	0.000209	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.45e-05	0.000209	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.39e-05	0.0002	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.24e-05	0.000178	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HPGD—prostate cancer	1.24e-05	0.000178	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.16e-05	0.000167	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—MTAP—prostate cancer	1.13e-05	0.000163	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.13e-05	0.000163	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.1e-05	0.000159	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.1e-05	0.000159	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ACSL4—prostate cancer	1.05e-05	0.000151	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.05e-05	0.000151	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PHGDH—prostate cancer	1.01e-05	0.000145	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ARG2—prostate cancer	1.01e-05	0.000145	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—UMPS—prostate cancer	1.01e-05	0.000145	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—LDHB—prostate cancer	9.88e-06	0.000142	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP3A5—prostate cancer	9.7e-06	0.00014	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—UCP3—prostate cancer	9.37e-06	0.000135	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TCN2—prostate cancer	9.37e-06	0.000135	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA3—prostate cancer	9.37e-06	0.000135	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PDHA1—prostate cancer	9.37e-06	0.000135	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC22A3—prostate cancer	8.94e-06	0.000129	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HSD3B1—prostate cancer	8.94e-06	0.000129	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.57e-06	0.000123	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA4—prostate cancer	8.57e-06	0.000123	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA2—prostate cancer	8.35e-06	0.00012	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.25e-06	0.000119	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ABCG5—prostate cancer	8.25e-06	0.000119	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA1—prostate cancer	8.06e-06	0.000116	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTO1—prostate cancer	7.97e-06	0.000115	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HSD3B2—prostate cancer	7.97e-06	0.000115	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NAT2—prostate cancer	7.97e-06	0.000115	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PLCB2—prostate cancer	7.64e-06	0.00011	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.64e-06	0.00011	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—LRP2—prostate cancer	7.64e-06	0.00011	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—P4HB—prostate cancer	7.49e-06	0.000108	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.29e-06	0.000105	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.1e-06	0.000102	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—MED12—prostate cancer	6.99e-06	0.000101	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GNG5—prostate cancer	6.93e-06	9.98e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NCOA3—prostate cancer	6.68e-06	9.61e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HPGDS—prostate cancer	6.37e-06	9.17e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.33e-06	9.11e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTT1—prostate cancer	6.18e-06	8.9e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ACHE—prostate cancer	6.18e-06	8.9e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.11e-06	8.79e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AKR1C3—prostate cancer	5.94e-06	8.55e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PRKACB—prostate cancer	5.91e-06	8.51e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.85e-06	8.42e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NCOA2—prostate cancer	5.57e-06	8.02e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.32e-06	7.65e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.19e-06	7.48e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NQO1—prostate cancer	5.13e-06	7.39e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TH—prostate cancer	5.06e-06	7.29e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.92e-06	7.09e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GGT1—prostate cancer	4.77e-06	6.86e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NCOA1—prostate cancer	4.7e-06	6.76e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.63e-06	6.66e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—RXRA—prostate cancer	4.47e-06	6.43e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—COMT—prostate cancer	4.3e-06	6.2e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTP1—prostate cancer	4.28e-06	6.17e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ITPR1—prostate cancer	4.21e-06	6.07e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TYMS—prostate cancer	3.98e-06	5.73e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTM1—prostate cancer	3.93e-06	5.67e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—LPL—prostate cancer	3.86e-06	5.56e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.73e-06	5.37e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ERCC2—prostate cancer	3.7e-06	5.33e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—MTHFR—prostate cancer	3.48e-06	5.01e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PPARA—prostate cancer	3.41e-06	4.91e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CAV1—prostate cancer	3.21e-06	4.62e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.92e-06	4.21e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—INS—prostate cancer	2.77e-06	3.98e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CREBBP—prostate cancer	2.71e-06	3.9e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.57e-06	3.7e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NOS3—prostate cancer	2.43e-06	3.49e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.24e-06	3.22e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTGS2—prostate cancer	2.22e-06	3.19e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTEN—prostate cancer	1.93e-06	2.79e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—EP300—prostate cancer	1.85e-06	2.66e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.36e-06	1.97e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AKT1—prostate cancer	1.11e-06	1.61e-05	CbGpPWpGaD
